Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Donny W Suh, AAPOS 2021: Ocular Manifestations of Abusive Head Trauma in Infants

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 4th 2021

Donny W Suh (Gavin Herbert Eye Institute, University of California at Irvine, Irvine, CA, USA) talked us through the ocular manifestations of abusive head trauma in infants and the challenges associated with diagnosis.

Questions

  1. Could you tell us about the ocular manifestations of abusive head trauma in infants and the challenges associated with diagnosis? (00:27)
  2. How common is retinal haemorrhage in abusive head trauma? (02:21)
  3. What can we deduce about abusive head trauma from the patterns of retinal haemorrhage? (02:52)

Speaker Disclosure: Donny W Suh has no financial or non-financial relationships or activities to declare in relation to this interview.

Support: Interview and filming supported by Touch Medical Media Ltd.

Filmed in coverage of AAPOS 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup